Lincoln Pharmaceuticals Limited (BOM:531633)
India
· Delayed Price · Currency is INR 615.55
-1.45 (-0.24%)
At close: Mar 9, 2026
Lincoln Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,329 | 11,047 | 11,725 | 6,784 | 6,230 | 4,494 | Upgrade
|
| Market Cap Growth | 9.85% | -5.78% | 72.84% | 8.89% | 38.64% | 67.94% | Upgrade
|
| Enterprise Value | 10,011 | 9,087 | 10,027 | 5,679 | 5,224 | 3,624 | Upgrade
|
| Last Close Price | 615.55 | 549.78 | 582.16 | 335.85 | 306.89 | 220.85 | Upgrade
|
| PE Ratio | 14.04 | 13.42 | 12.57 | 9.31 | 8.98 | 7.22 | Upgrade
|
| Forward PE | - | 13.25 | 13.25 | 13.25 | 13.25 | 13.25 | Upgrade
|
| PS Ratio | 1.89 | 1.77 | 2.02 | 1.33 | 1.32 | 1.06 | Upgrade
|
| PB Ratio | 1.72 | 1.65 | 1.98 | 1.35 | 1.44 | 1.23 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.65 | 1.98 | 1.35 | 1.44 | 1.23 | Upgrade
|
| P/FCF Ratio | - | 14.93 | 49.39 | 27.13 | 20.36 | 7.43 | Upgrade
|
| P/OCF Ratio | - | 11.88 | 18.55 | 17.28 | 8.18 | 6.49 | Upgrade
|
| PEG Ratio | - | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | Upgrade
|
| EV/Sales Ratio | 1.54 | 1.46 | 1.73 | 1.11 | 1.11 | 0.85 | Upgrade
|
| EV/EBITDA Ratio | 9.90 | 8.86 | 10.02 | 6.34 | 5.46 | 4.16 | Upgrade
|
| EV/EBIT Ratio | 11.55 | 10.13 | 11.19 | 7.05 | 5.96 | 4.54 | Upgrade
|
| EV/FCF Ratio | - | 12.28 | 42.23 | 22.71 | 17.07 | 5.99 | Upgrade
|
| Debt / Equity Ratio | 0 | - | 0.00 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | - | 0.01 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.05 | 0.08 | 0.07 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.29 | -0.25 | -0.21 | -0.26 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.29 | -1.91 | -1.51 | -1.18 | -1.18 | -1.08 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.64 | -6.38 | -4.24 | -3.69 | -1.55 | Upgrade
|
| Asset Turnover | - | 0.83 | 0.90 | 0.91 | 0.96 | 1.01 | Upgrade
|
| Inventory Turnover | - | 3.81 | 3.85 | 3.44 | 3.72 | 4.29 | Upgrade
|
| Quick Ratio | - | 3.41 | 3.41 | 3.39 | 2.56 | 2.74 | Upgrade
|
| Current Ratio | - | 4.71 | 4.74 | 5.09 | 3.90 | 4.07 | Upgrade
|
| Return on Equity (ROE) | - | 13.02% | 17.04% | 15.59% | 17.36% | 18.31% | Upgrade
|
| Return on Assets (ROA) | - | 7.49% | 8.70% | 8.97% | 11.11% | 11.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.66% | 14.75% | 16.32% | 16.32% | 21.41% | 21.79% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 13.00% | 14.70% | 15.60% | 19.80% | 21.20% | Upgrade
|
| Earnings Yield | 7.12% | 7.45% | 7.96% | 10.75% | 11.13% | 13.85% | Upgrade
|
| FCF Yield | - | 6.70% | 2.02% | 3.69% | 4.91% | 13.47% | Upgrade
|
| Dividend Yield | 0.29% | 0.33% | 0.31% | 0.45% | 0.49% | 0.68% | Upgrade
|
| Payout Ratio | - | 4.38% | 3.22% | 4.12% | 4.33% | - | Upgrade
|
| Buyback Yield / Dilution | 0.01% | - | - | - | - | -0.15% | Upgrade
|
| Total Shareholder Return | 0.30% | 0.33% | 0.31% | 0.45% | 0.49% | 0.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.